Incidence and risk factors for hepatitis C seroconversion in hemodialysis: a prospective study. The UCL Collaborative Group (Q43035394)

12 November 2017

Incidence and risk factors for hepatitis C seroconversion in hemodialysis: a prospective study. The UCL Collaborative Group (English)

1 reference

12 November 2017

1 reference

1 reference

1 reference

Jadoul M

1

1 reference

12 November 2017

Cornu C

series ordinal

2

1 reference

12 November 2017

van Ypersele de Strihou C

series ordinal

3

1 reference

12 November 2017

language of work or name

English

0 references

publication date

1 December 1993

1 reference

12 November 2017

1 reference

12 November 2017

44

1 reference

12 November 2017

6

1 reference

12 November 2017

1322-1326

1 reference

https://scigraph.springernature.com/pub.10.1038/ki.1993.385

12 November 2017

0 references

cites work

Second-Generation Tests for Hepatitis C Virus

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.385

7 January 2021

Hepatitis C infection in two urban hemodialysis units

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.385

7 January 2021

Risk factors for dialysis-associated hepatitis C in Venezuela

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.385

7 January 2021

The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.385

7 January 2021

Hepatitis C virus infection in chronic haemodialysis patients, a clinicopathologic study

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.385

7 January 2021

Prevalence of anti-HCV and HCV viremia in hemodialysis patients in Taiwan

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.385

7 January 2021

Improved serodiagnosis of posttransfusion hepatitis C virus infection by a second-generation immunoassay based on multiple recombinant antigens

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.385

7 January 2021

Confirmation of hepatitis C virus infection by new four-antigen recombinant immunoblot assay

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.385

7 January 2021

CHEMICAL, CLINICAL, AND IMMUNOLOGICAL STUDIES ON THE PRODUCTS OF HUMAN PLASMA FRACTIONATION. XXXVI. INACTIVATION OF THE VIRUS OF HOMOLOGOUS SERUM HEPATITIS IN SOLUTIONS OF NORMAL HUMAN SERUM ALBUMIN BY MEANS OF HEAT.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.385

7 January 2021

False-positive hepatitis C virus antibody tests in paraproteinaemia

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.385

7 January 2021

Long-term follow-up of anti-hepatitis C virus antibodies in patients with acute nonA nonB hepatitis and different outcome of liver disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.385

7 January 2021

Transmission of anti-HCV within the household of haemodialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.385

7 January 2021

Direct detection of circulating hepatitis C virus RNA using probes from the 5' untranslated region

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.385

7 January 2021

Lack of Protective Immunity Against Reinfection with Hepatitis C Virus

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.385

7 January 2021

Prevalence of hepatitis C virus RNA in organ donors positive for hepatitis C antibody and in the recipients of their organs

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.385

7 January 2021

Outbreak of hemodialysis-associated non-A, non-B hepatitis and correlation with antibody to hepatitis C virus

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.385

7 January 2021

Identifiers

DOI

10.1038/KI.1993.385

1 reference

12 November 2017

1 reference